Table 3 Grouping and treatment with the Pi3k inhibitor LY294002.
Groups | Treatment of LY294002 | Treatment of FNB |
|---|---|---|
LY group | 50 μM LY29400 | RPMI-1640 |
LY + FNB group | 50 μM LY29400 | RPMII-1640 with 75 μg/mL FNB |
FNB group | RPMI-1640 | RPMII-1640 with 75 μg/mL FNB |
Control group | RPMI-1640 | RPMI-1640 |